Related Experiment Video
Updated: Jan 14, 2026

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
Published on: June 7, 2024
Cancer cells co-opt an inter-organ neuroimmune circuit to escape immune surveillance
Yu Zhang1, Yibo Guo2, Zheqi Liu3
1Department of Oral and Maxillofacial Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China; Department of Stomatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Abstract:
Whether and how cancer exploits distant organs to escape immune surveillance remains largely unknown. Using clinical data from head and neck squamous cell carcinoma (HNSCC) patients and three murine oral cancer models, we find that cancer cells under immune pressure secrete slit guidance ligand 2 (SLIT2) through an activating transcription factor 4 (ATF4)-dependent pathway, which activates tumor-innervating nociceptive neurons and aggravates cancer-induced pain. This activation then stimulates tumor-draining lymph-node (TDLN)-innervating nociceptive neurons and increases calcitonin gene-related peptide (CGRP) secretion, remodeling TDLNs into an immune-suppressed state. Consequently, decreased CCL5 secretion from immune-suppressed TDLNs promotes M2-like polarization of tumor-associated macrophages, facilitating tumor growth and reducing immune checkpoint blockade (ICB) efficacy. Targeting nociceptive neurons or the ATF4-SLIT2-CGRP axis restores immune activity, alleviates cancer-induced pain, and improves ICB responses. Our findings reveal an inter-organ neuroimmune circuit co-opted by cancer to escape immune surveillance, suggesting potential therapeutic strategies to enhance immunotherapy.
Insights
Cancer cells escape immune surveillance by activating pain pathways, which suppress anti-tumor immunity. Targeting this neuroimmune circuit can restore immune function and improve immunotherapy efficacy.
Area of Science:
- Oncology
- Neuroimmunology
- Cancer Immunology
Background:
- Cancer immune evasion is a critical challenge in oncology.
- The role of distant organ interactions in cancer immune escape is poorly understood.
- Head and neck squamous cell carcinoma (HNSCC) provides a model to study these mechanisms.
Purpose of the Study:
- To elucidate the mechanisms by which cancer exploits distant organs to evade immune surveillance.
- To investigate the role of the nervous system in cancer-induced immune suppression.
- To identify potential therapeutic targets for enhancing cancer immunotherapy.
Main Methods:
- Analysis of clinical data from HNSCC patients.
- Utilized three murine oral cancer models.
- Investigated the ATF4-SLIT2-CGRP signaling axis and its impact on nociceptive neurons and lymph nodes.
Main Results:
- Cancer cells under immune pressure secrete SLIT2 via ATF4, activating nociceptive neurons and causing pain.
- This neuronal activation suppresses anti-tumor immunity in tumor-draining lymph nodes (TDLNs) by reducing CCL5 and promoting M2 macrophage polarization.
- This immune suppression facilitates tumor growth and diminishes the effectiveness of immune checkpoint blockade (ICB).
Conclusions:
- Cancer establishes an inter-organ neuroimmune circuit to escape immune surveillance.
- Targeting nociceptive neurons or the ATF4-SLIT2-CGRP pathway can restore anti-tumor immunity.
- This approach may enhance immunotherapy responses and alleviate cancer pain.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Psychoneuroimmunology: Diabetes and Cancer
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Cell Migration through Invadopodia
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

